eF-site ID 5zrf-AB
PDB Code 5zrf
Chain A, B

click to enlarge
Title Crystal structure of human topoisomerase II beta in complex with 5-iodouridine-containing-DNA and etoposide in space group p21
Classification ISOMERASE/DNA
Compound DNA topoisomerase 2-beta
Source (5ZRF)
Sequence A:  KGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGV
IGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVG
LQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLIN
FIHHNWPSLLKHGFLEEFITKEAKEYFADMERHRILFRYA
GPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHKHL
TYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLFTC
FKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNLAQ
NFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLSTL
ARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLINGA
EGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPNYK
NFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTWTQ
VYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVKMT
EEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKKYE
TVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQAR
FILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWKEA
QEGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVNDLK
RKSPSDLWKEDLAAFVEELDKVESQERED
B:  SKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSG
LGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIK
IVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGL
LINFIHHNWPSLLKHGFLEEFITPAKEAKEYFADMERHRI
LFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRR
LHGTKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQ
RKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMM
TIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYI
FTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIP
MVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPH
PMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITEL
PVRTWTQVYKEQVLEPMLNGPALISDYKEYHTDTTVKFVV
KMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLK
KYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNN
QARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAW
KEAQGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVND
LKRKSPSDLWKEDLAAFVEELDKVESQERED
Description


Functional site

1) chain A
residue 557
type
sequence D
description binding site for residue MG A 1301
source : AC1

2) chain A
residue 559
type
sequence D
description binding site for residue MG A 1301
source : AC1

3) chain A
residue 867
type
sequence N
description binding site for residue MG A 1302
source : AC2

4) chain A
residue 868
type
sequence G
description binding site for residue MG A 1302
source : AC2

5) chain B
residue 867
type
sequence N
description binding site for residue MG B 1301
source : AC3

6) chain B
residue 868
type
sequence G
description binding site for residue MG B 1301
source : AC3

7) chain B
residue 557
type
sequence D
description binding site for residue MG B 1302
source : AC4

8) chain B
residue 559
type
sequence D
description binding site for residue MG B 1302
source : AC4

9) chain B
residue 478
type
sequence G
description binding site for residue EVP D 101
source : AC5

10) chain B
residue 479
type
sequence D
description binding site for residue EVP D 101
source : AC5

11) chain B
residue 503
type
sequence R
description binding site for residue EVP D 101
source : AC5

12) chain B
residue 778
type
sequence Q
description binding site for residue EVP D 101
source : AC5

13) chain B
residue 782
type
sequence M
description binding site for residue EVP D 101
source : AC5

14) chain A
residue 478
type
sequence G
description binding site for residue EVP F 1301
source : AC7

15) chain A
residue 479
type
sequence D
description binding site for residue EVP F 1301
source : AC7

16) chain A
residue 503
type
sequence R
description binding site for residue EVP F 1301
source : AC7

17) chain A
residue 782
type
sequence M
description binding site for residue EVP F 1301
source : AC7

18) chain A
residue 479
type
sequence D
description binding site for Di-nucleotide IU D 9 and DG D 10
source : AC9

19) chain B
residue 820
type
sequence R
description binding site for Di-nucleotide IU D 9 and DG D 10
source : AC9

20) chain B
residue 821
type
sequence Y
description binding site for Di-nucleotide IU D 9 and DG D 10
source : AC9

21) chain B
residue 505
type
sequence K
description binding site for Di-nucleotide DC D 14 and IU D 15
source : AD1

22) chain B
residue 506
type
sequence I
description binding site for Di-nucleotide DC D 14 and IU D 15
source : AD1

23) chain B
residue 507
type
sequence L
description binding site for Di-nucleotide DC D 14 and IU D 15
source : AD1

24) chain B
residue 508
type
sequence N
description binding site for Di-nucleotide DC D 14 and IU D 15
source : AD1

25) chain B
residue 516
type
sequence Q
description binding site for Di-nucleotide DC D 14 and IU D 15
source : AD1

26) chain B
residue 564
type
sequence H
description binding site for Di-nucleotide DC D 14 and IU D 15
source : AD1

27) chain B
residue 506
type
sequence I
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

28) chain B
residue 507
type
sequence L
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

29) chain B
residue 508
type
sequence N
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

30) chain B
residue 564
type
sequence H
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

31) chain B
residue 669
type
sequence F
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

32) chain B
residue 872
type
sequence I
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

33) chain B
residue 873
type
sequence G
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

34) chain B
residue 874
type
sequence T
description binding site for Di-nucleotide IU D 15 and DC D 16
source : AD2

35) chain A
residue 897
type
sequence D
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

36) chain A
residue 899
type
sequence L
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

37) chain B
residue 879
type
sequence K
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

38) chain B
residue 1010
type
sequence T
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

39) chain B
residue 1011
type
sequence L
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

40) chain B
residue 1012
type
sequence T
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

41) chain B
residue 1014
type
sequence N
description binding site for Di-nucleotide DC D 19 and IU D 20
source : AD3

42) chain A
residue 821
type
sequence Y
description binding site for Di-nucleotide IU F 9 and DG F 10
source : AD4

43) chain B
residue 479
type
sequence D
description binding site for Di-nucleotide IU F 9 and DG F 10
source : AD4

44) chain A
residue 505
type
sequence K
description binding site for Di-nucleotide DC F 14 and IU F 15
source : AD5

45) chain A
residue 506
type
sequence I
description binding site for Di-nucleotide DC F 14 and IU F 15
source : AD5

46) chain A
residue 507
type
sequence L
description binding site for Di-nucleotide DC F 14 and IU F 15
source : AD5

47) chain A
residue 508
type
sequence N
description binding site for Di-nucleotide DC F 14 and IU F 15
source : AD5

48) chain A
residue 516
type
sequence Q
description binding site for Di-nucleotide DC F 14 and IU F 15
source : AD5

49) chain A
residue 564
type
sequence H
description binding site for Di-nucleotide DC F 14 and IU F 15
source : AD5

50) chain A
residue 506
type
sequence I
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

51) chain A
residue 507
type
sequence L
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

52) chain A
residue 508
type
sequence N
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

53) chain A
residue 564
type
sequence H
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

54) chain A
residue 669
type
sequence F
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

55) chain A
residue 872
type
sequence I
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

56) chain A
residue 873
type
sequence G
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

57) chain A
residue 874
type
sequence T
description binding site for Di-nucleotide IU F 15 and DC F 16
source : AD6

58) chain A
residue 879
type
sequence K
description binding site for Di-nucleotide DC F 19 and IU F 20
source : AD7

59) chain A
residue 1010
type
sequence T
description binding site for Di-nucleotide DC F 19 and IU F 20
source : AD7

60) chain A
residue 1011
type
sequence L
description binding site for Di-nucleotide DC F 19 and IU F 20
source : AD7

61) chain A
residue 1012
type
sequence T
description binding site for Di-nucleotide DC F 19 and IU F 20
source : AD7

62) chain A
residue 1014
type
sequence N
description binding site for Di-nucleotide DC F 19 and IU F 20
source : AD7

63) chain A
residue 1015
type
sequence S
description binding site for Di-nucleotide DC F 19 and IU F 20
source : AD7

64) chain A
residue 475-483
type prosite
sequence LTEGDSAKS
description TOPOISOMERASE_II DNA topoisomerase II signature. LTEGDSAKS
source prosite : PS00177

65) chain A
residue 821
type ACT_SITE
sequence Y
description O-(5'-phospho-DNA)-tyrosine intermediate => ECO:0000255|PROSITE-ProRule:PRU01384, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI1

66) chain B
residue 821
type ACT_SITE
sequence Y
description O-(5'-phospho-DNA)-tyrosine intermediate => ECO:0000255|PROSITE-ProRule:PRU01384, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI1

67) chain A
residue 477
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI2

68) chain B
residue 477
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI2

69) chain A
residue 557
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

70) chain A
residue 559
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

71) chain B
residue 557
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

72) chain B
residue 559
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

73) chain A
residue 505
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

74) chain B
residue 678
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

75) chain B
residue 739
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

76) chain B
residue 947
type SITE
sequence W
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

77) chain A
residue 508
type SITE
sequence N
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

78) chain A
residue 677
type SITE
sequence R
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

79) chain A
residue 678
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

80) chain A
residue 739
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

81) chain A
residue 947
type SITE
sequence W
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

82) chain B
residue 505
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

83) chain B
residue 508
type SITE
sequence N
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

84) chain B
residue 677
type SITE
sequence R
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

85) chain A
residue 773
type SITE
sequence Y
description Interaction with DNA => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI5

86) chain B
residue 773
type SITE
sequence Y
description Interaction with DNA => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI5

87) chain A
residue 820
type SITE
sequence R
description Transition state stabilizer
source Swiss-Prot : SWS_FT_FI6

88) chain B
residue 820
type SITE
sequence R
description Transition state stabilizer
source Swiss-Prot : SWS_FT_FI6

89) chain A
residue 872
type SITE
sequence I
description Important for DNA bending; intercalates between base pairs of target DNA
source Swiss-Prot : SWS_FT_FI7

90) chain B
residue 872
type SITE
sequence I
description Important for DNA bending; intercalates between base pairs of target DNA
source Swiss-Prot : SWS_FT_FI7

91) chain B
residue 641
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

92) chain B
residue 671
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

93) chain B
residue 707
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

94) chain B
residue 1087
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

95) chain A
residue 641
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

96) chain A
residue 671
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

97) chain A
residue 707
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

98) chain A
residue 1087
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

99) chain A
residue 638
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI9

100) chain B
residue 638
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI9


Display surface

Download
Links